Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS Patients
Rationale: Acute respiratory distress syndrome (ARDS) is a major global health concern with a significant unmet need. EXO-CD24 is delivered via inhalation-reduced cytokines and chemokine secretion and lung injury in ARDS and improved survival in mice models of ARDS, influenza, and sepsis. Objectives...
Main Authors: | Orr Green, Gil Shenberg, Roni Baruch, Lihi Argaman, Talya Levin, Ian Michelson, Ruthy Hadary, Boris Isakovich, Miri Golos, Reut Schwartz, Ronan MacLoughlin, Nimrod Adi, Nadir Arber, Shiran Shapira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/9/2523 |
Similar Items
-
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond
by: Shiran Shapira, et al.
Published: (2022-07-01) -
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
by: Ioannis Grigoropoulos, et al.
Published: (2024-04-01) -
Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review
by: Georgios Tsioulos, et al.
Published: (2022-09-01) -
Targeting CD24 in Cancer Immunotherapy
by: Wenwen Chen, et al.
Published: (2023-11-01) -
Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
by: Farid RM, et al.
Published: (2019-05-01)